Cargando…
MSCs and their exosomes: a rapidly evolving approach in the context of cutaneous wounds therapy
Currently, mesenchymal stem/stromal stem cell (MSC) therapy has become a promising option for accelerating cutaneous wound healing. In vivo reports have outlined the robust competences of MSCs to offer a solid milieu by inhibition of inflammatory reactions, which in turn, enables skin regeneration....
Autores principales: | Marofi, Faroogh, Alexandrovna, Kozlitina Iuliia, Margiana, Ria, Bahramali, Mahta, Suksatan, Wanich, Abdelbasset, Walid Kamal, Chupradit, Supat, Nasimi, Maryam, Maashi, Marwah Suliman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642895/ https://www.ncbi.nlm.nih.gov/pubmed/34863308 http://dx.doi.org/10.1186/s13287-021-02662-6 |
Ejemplares similares
-
Mesenchymal Stem/Stromal Cells as a Vehicle for Cytokine Delivery: An Emerging Approach for Tumor Immunotherapy
por: Razeghian, Ehsan, et al.
Publicado: (2021) -
A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine
por: Moghadasi, Soudeh, et al.
Publicado: (2021) -
Hurdles to breakthrough in CAR T cell therapy of solid tumors
por: Marofi, Faroogh, et al.
Publicado: (2022) -
Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor (CAR) for tumor immunotherapy; recent progress
por: Budi, Hendrik Setia, et al.
Publicado: (2022) -
Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges
por: Razeghian, Ehsan, et al.
Publicado: (2021)